Blog

The most abundant immunosuppressive molecule in a solid tumour is not a protein. It is adenosine — a metabolite, produced from ATP in two enzymatic steps, at concentrations orders of magnitude above those found in healthy tissue. It is not secreted by a specialised cell type, it cannot be knocked out, and it acts on every immune cell that carries a receptor for it. Understanding how a danger signal becomes its own antidote is the most useful thing you can know about the tumour microenvironment that checkpoint biology does not tell you. HYPOXIC, DYING TISSUE — ATP IS RELEASED AS A DANGER SIGNALCELL SURFACE — ECTONUCLEOTIDASEScAMP → PKA — THE SUPPRESSIVE SIGNALSUPPRESSED CYTOTOXICITYSEL …

QUICK ANSWER On a Human I-FABP/FABP2 ColorStep ELISA, the top of the standard curve looked perfect while the three lowest standards showed duplicate %CVs of 37–450% — because their optical density (OD) sat right at the blank. Near the bottom of the working range, a few milli-OD of well-to-well noise becomes a huge relative error, and dual-wavelength (OD450–620) subtraction pushed near-zero wells negative. The fix: keep the curve inside the validated 0.156–10 ng/mL range, retain single-wavelength OD450, and bring low samples up into the reliable mid-curve (run neat or concentrate). QC confirmed no kit defect. On this page The pro …

An antibody's variable domains decide what it binds. Its Fc decides what happens next — and that is not a detail of formulation, it is half the mechanism. Which Fcγ receptor the constant region engages determines whether an opsonised cell is killed by an NK cell, eaten by a macrophage, lysed by complement, or simply ignored. It also determines whether your isotype control is a control at all. This article walks the Fcγ receptor family, the single kinase cascade they share, the one inhibitory receptor that subtracts from all of it, and the three effector mechanisms they feed — plus FcRn, which does none of the above and yet sets the half-life of the whole molecule. Ke …

Both interferon families run through STAT1, and that single shared subunit is why they are so often conflated — and why conflating them is a mistake. Type I interferon assembles STAT1 into a three-part complex with STAT2 and IRF9 that reads one class of promoter element. Type II interferon assembles STAT1 into a homodimer that reads a different one. Same phospho-STAT1 band on a blot; two largely non-overlapping gene programmes; two different reasons to block them. This article walks both arms from induction to output, and ends with the part that matters commercially: the fact that the interferon a successful T-cell response produces is also the signal that installs the brake …

Transplant rejection is the fastest, most violent adaptive immune response a body can mount — and it is a response to a molecule rather than to a pathogen. Somewhere between one and ten per cent of a recipient’s naive T-cell repertoire will react to a mismatched MHC molecule, which is orders of magnitude above the frequency for a conventional antigen. That single number explains why an untreated allograft fails in days, why the immunology of transplantation has its own vocabulary, and why the antibody toolkit for studying it is unusually deep. This article walks the pathway from the mismatched MHC molecule itself through the three recognition routes, the synapse they share, the …

PD-1 gets the attention, but it is one brake among many — and the others do not work the same way. The co-inhibitory receptors are routinely drawn as interchangeable stop signs on a T cell. They are nothing of the kind. They read different ligands, engage different intracellular machinery, and in one case do not signal into the T cell at all so much as strip the antigen-presenting cell of the molecules it needs to stimulate. Understanding which mechanism each receptor uses is the difference between a rational combination and a hopeful one. Key takeaways CTLA-4 does not merely outcompete CD28 — it removes CD80 and CD86 from the antigen-presenting cell by trans-endocytosis, making …

The neutrophil is the most heavily armed short-lived cell in the body. It leaves the marrow with its weapons already made — granules preloaded with elastase, myeloperoxidase and defensins — and spends most of its life doing nothing. Activation is therefore not about building an effector programme but about releasing one, in stages, against a gradient. Get the staging wrong and the machinery that sterilises an abscess produces acute lung injury, immunothrombosis or ANCA vasculitis. This map follows the sequence from priming to PAD4-driven NETosis and the signals that switch it off. Key takeaways Priming and activation are separate events. TNF, GM-CSF and LPS raise the response ce …

A macrophage does not decide to eat; it counts votes. Every particle it touches carries a mixture of pro-phagocytic and inhibitory ligands, and engulfment follows only when the activating tally clears a threshold set locally at the contact site. That arithmetic is why a healthy erythrocyte survives a splenic transit while an antibody-coated tumour cell does not, and why CD47 blockade became one of the most heavily pursued targets in innate immuno-oncology. Key takeaways Phagocytosis is a balance: opsonic and apoptotic-cell eat-me ligands against don't-eat-me ligands read by ITIM receptors. The activating arm runs FcγR → FcRγ ITAM → Lyn → Syk → PI3Kδ &ra …

Every leukocyte that reaches an inflamed tissue has solved the same mechanical problem. It must stop, in under a second, against a shear flow that would otherwise sweep it past the site of infection. The solution is not one adhesion event but a strictly ordered cascade — capture, rolling, chemokine-triggered arrest, spreading, crawling and diapedesis — in which each step licenses the next. The logic is unusually well defined, the human loss-of-function phenotypes are unambiguous, and almost every node is druggable. Key takeaways Recruitment is sequential: selectins capture and roll, chemokines signal arrest, integrins hold, junctional molecules permit diapedesis. P-selectin is p …

Quick answer: A researcher subtracted the blank from a competitive ELISA (a Serotonin kit) and every result turned negative. In a competitive assay the signal is inversely proportional to concentration, so the blank (zero standard) gives the highest optical density — subtracting it drives all readings below zero. Do not subtract the blank in a competitive ELISA. Blank subtraction belongs to sandwich ELISAs (like the researcher’s Zonulin kit), where signal rises with concentration and the blank is the lowest value. On this page The problem The data Why it happens Our analysis Root cause What we recommended Ke …

Toll-like receptors are the reason a milligram of endotoxin can kill a mouse. They are the fastest, least discriminating layer of immunity: germline-encoded sensors that read conserved microbial chemistry and, within minutes, commit a cell to an inflammatory or an interferon programme. The pathway looks simple in outline — ligand, receptor, adaptor, transcription factor — but almost everything that matters is decided by two variables: which compartment the receptor sits in, and which adaptor it recruits. Key takeaways TLRs split by address: TLR2 (1/6), TLR4 and TLR5 read surface chemistry; TLR3, TLR7 and TLR9 are confined to endosomes. That confinement is the self/non-self trick …

Every T-cell response begins with a protein being taken apart. Before a CD8 or CD4 T cell can see anything, an antigen has to be degraded into peptides of the right length, delivered to the right compartment, edited against a competing pool of self peptides and displayed on a class I or class II molecule that survives long enough to reach the surface. Three semi-independent routes do this — the proteasomal class I pathway, the endosomal class II pathway, and cross-presentation — and the differences between them decide whether an immunogen produces cytotoxic immunity, helper immunity, or tolerance. Key takeaways Class I peptides come mainly from proteasomal degradation of newly s …

Apoptosis is not one pathway but three routes into the same execution machinery. A death ligand at the surface, a mitochondrion that loses outer-membrane integrity, and a granzyme delivered by a cytotoxic lymphocyte all end at the same place: caspase-3 cleaving hundreds of cellular substrates in an orderly sequence. What differs is the entry point, the brakes that must be removed first, and — critically for anyone designing an experiment — which readout will actually report that the decision has been made. Key takeaways The extrinsic arm runs ligand → receptor → FADD/TRADD → caspase-8; the intrinsic arm runs stress → BH3-only proteins → BAX/BAK → cy …

PI3K does not switch on a protein — it rewrites a membrane. Everything downstream follows from one chemical event: the 3-hydroxyl of a phosphoinositide is phosphorylated, PIP₂ becomes PIP₃, and every PH-domain protein in the cytosol suddenly has somewhere to dock. In a T cell that single change converts antigen recognition into growth, glycolysis and a choice between a short-lived effector and a memory cell. Reading the pathway well means knowing which phosphorylations are causal, which are merely convenient readouts, and where the brakes sit. Key takeaways Class IA PI3K in lymphocytes is the p85–p110δ dimer; the second messenger is a lipid, which is why PTEN a …

NF-κB is not one pathway, it is two clocks running at different speeds. The canonical arm fires within minutes of TNF-α, IL-1β or LPS reaching the surface, peaks, and is switched off by feedback it encodes itself. The non-canonical arm takes hours, needs new protein synthesis, and is driven not by a kinase cascade but by the disappearance of a ubiquitin ligase. Most inflammatory phenotypes worth modelling ask which clock is running, and for how long. Key takeaways Canonical signalling frees p50/p65 (RelA) in minutes by destroying IκBα; the non-canonical arm slowly processes p100 to p52 for RelB. The proximal machinery is a ubiquitin code, not a kinase cascade: c …

Dozens of cytokines converge on four kinases and seven transcription factors. That compression is the problem JAK–STAT has to solve, and it is why this map is drawn as receptor, kinase and STAT columns rather than a linear cascade. Specificity is not built into the kinases — JAK1 serves the interferons, IL-6 and IL-2 alike. It is built into which receptor tail a STAT can dock on, which promoter element the resulting dimer reads, and which brake closes that arm first. Key takeaways Cytokine receptors have no catalytic domain; signalling is delegated to JAK1, JAK2, JAK3 and TYK2 pre-docked on the membrane-proximal box1/box2 motif. JAK3 pairs only with the common γ-chain (IL2 …

Almost all of the TGF-β in a tissue is already there, and almost none of it is active. That single fact reorganises how the pathway should be studied. Unlike most cytokines, TGF-β is deposited into the matrix in a latent complex and held there; the regulated step is not transcription or secretion but mechanical release by integrins such as αvβ6. Everything downstream — receptor assembly, SMAD phosphorylation, the fibrotic and EMT programmes — is a fast, reversible relay hung off that slow, mechanically gated switch. Key takeaways TGF-β is secreted latent; activation is a mechanical event driven by integrins including αvβ6, not a change in exp …

A chimeric antigen receptor is a synthetic protein wired into a real signalling pathway. The extracellular half is an antibody fragment; everything below the membrane is borrowed from the T-cell receptor complex and its costimulatory partners. That hybrid design is why CAR-T therapy works, and why its two defining problems — cytokine release syndrome and loss of persistence — are signalling problems rather than manufacturing ones. Reading the pathway from CD19 engagement to granzyme B release shows where each failure is generated. Key takeaways A CAR fuses an anti-CD19 scFv to a CD3ζ tail: recognition is antibody-like and MHC-independent, but signalling is T-cell-like. LCK …

Double-stranded DNA in the cytosol is always a mistake. A virus has uncoated, a mitochondrion has ruptured, a micronucleus has burst, or a chromosome has been broken and left unrepaired. cGAS treats all of these identically: it binds the sugar-phosphate backbone without reading a base, makes a cyclic dinucleotide, and hands the alarm to STING. What follows — interferon, inflammation, autophagy or death — is decided by trafficking and by a set of brakes as important as the sensor itself. Key takeaways cGAS senses the DNA backbone, not sequence: it ladders along long duplexes and phase-separates, making the response switch-like rather than graded. 2′3′-cGAMP is transmi …

Quick answer On the Dog Beta-endorphin (BEP) ELISA Kit, a researcher ran the same canine serum aliquots on two plates from the same lot and saw roughly double the concentration on one plate versus the other. The standard curves on every run were valid and the lot’s QC precision was strong (inter-assay CV ≈ 6.8%), so the kit chemistry was working. The discrepancy traced to sample-level handling and an undiluted-serum matrix effect on a single run — not a kit fault. Diluting serum into the mid-range of the curve and tightening pipetting resolved it. On this page Click any section below to jump straight to it ↓ The pr …

The T-cell receptor is the most finely calibrated detector in immunology. It must discriminate an agonist peptide present at a few dozen copies from a self peptide present at tens of thousands, and it does so with a receptor that has no catalytic activity of its own. Every downstream event — the calcium flux, the Ras switch, the NF-κB translocation, the IL-2 burst — is built from borrowed kinases, adaptors with no enzymatic function, and phosphatases that decide how much signal survives. Key takeaways The TCR/CD3 complex has no kinase domain; proximal signalling is delegated to Lck, held in place by the CD4 or CD8 co-receptor. CD45 and Csk set the Lck set-point — the …

The antigen tells a CD4 T cell to respond; the cytokine tells it what kind of response to make. A naive CD4⁺ T cell leaving the thymus is uncommitted. Within about seventy-two hours of engaging TCR/CD3 and CD28 it will have chosen a transcriptional programme it largely keeps for life. That choice is made by whichever cytokines happen to be at the synapse, transduced by a specific STAT and locked in by a master transcription factor. Get the cytokine milieu wrong in a model and you get the wrong disease. Key takeaways Differentiation needs three inputs: signal 1 (TCR/CD3), signal 2 (CD28) and signal 3 (cytokine) — only the third is instructive about lineage. Each branch is a cytok …

Almost any inflammatory phenotype in a mouse can be assigned to a cytokine by taking that cytokine away. Neutralisation is the most direct causal test immunology has: inject a functional-grade antibody, remove one soluble signal, and watch the phenotype. But cytokines are not a cascade. They are parallel ligand–receptor pairs feeding a small set of shared transcription factors, and knowing which pairs share an output separates a clean blocking experiment from an uninterpretable one. Key takeaways TNF-α and IL-1 converge on NF-κB, so blocking either alone usually gives a partial phenotype. Type I and type II interferons use separate receptors but both drive STAT1; only rece …

In most solid tumours the largest immune population is not a T cell. It is a myeloid cell that has been recruited, expanded and re-educated by the tumour itself. Tumour-associated macrophages and myeloid-derived suppressor cells arise from the same monocytic and granulocytic precursors as protective myeloid cells; what differs is the signalling environment they mature in. Three input axes — CSF-1, GM-CSF and CCL2 — feed a small set of kinases and transcription factors that decide whether the resulting cell suppresses immunity or restores it. Key takeaways Tumour myeloid biology has three inputs: CSF-1→CSF-1R for survival, GM-CSF→GM-CSFR for expansion and CCL2→CCR2 …